Supreme Court preserves access to abortion pill, rejecting challenge
The Supreme Court on Thursday tossed out a challenge targeting the availability of a widely used abortion pill, preserving access to the drug.
Watch CBS News
The Supreme Court on Thursday tossed out a challenge targeting the availability of a widely used abortion pill, preserving access to the drug.
The Supreme Court on Thursday issued a unanimous ruling in favor of preserving access to the widely-used abortion pill mifepristone. It marked the high court's first major abortion decision since the overturning of Roe v. Wade nearly two years ago. Jan Crawford has more.
The Supreme Court issued a unanimous ruling preserving access to the abortion pill mifepristone on Thursday. The justices ruled that the group of anti-abortion rights doctors who sued the FDA did not have the legal grounds to do so. CBS News legal contributor Jessica Levinson breaks down the decision.
The Supreme Court on Thursday preserved access to mifepristone, the nation's most prescribed abortion drug. Jan Crawford, CBS News chief legal correspondent, and Elizabeth Sepper, professor of law at the University of Texas at Austin, join "America Decides" to unpack the ruling.
The Supreme Court ruled unanimously Thursday rejecting a challenge that could have prevented access to the abortion pill mifepristone. CBS News chief legal correspondent Jan Crawford reports.
The Supreme Court's unanimous ruling over the widely used mifepristone pill didn't have much to do with abortion access but instead focused on procedural grounds. CBS News legal contributor Jessica Levinson breaks down the decision.
The Supreme Court has unanimously rejected a bid to restrict access to the abortion pill Mifepristone, saying the parties who brought the case lacked legal standing to do so. CBS News legal contributor Jessica Levinson, chief legal correspondent Jan Crawford and campaign reporter Shawna Mizelle have more on the ruling.
The Supreme Court decided unanimously Thursday to toss a challenge to the availability of the mifepristone abortion pill, preserving access to the drug. The decision is based on procedural grounds and does not prevent future cases over access to the drug. CBS News' Jessica Levinson, Shawna Mizelle and Jan Crawford had more on the ruling. And for analysis of the decision, CBS News was joined by University of Texas at Austin professor of law Elizabeth Sepper and Dr. Ushma Upadhyay, a professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF.
CBS News' Haley Ott looks at how Alliance Defending Freedom, the U.S. Christian legal group that was behind the Supreme Court case over the abortion drug mifepristone, is expanding its fight far from U.S. shores.
The Supreme Court on Thursday unanimously rejected a challenge to the availability of mifepristone, a widely-used abortion pill. The ruling was based on procedural grounds and does not prevent future challenges to the drug's access. Norah O'Donnell anchored CBS News' special report on the decision.
The abortion pill legislation could be a template for other states to take aim at the medication commonly used in early-stage pregnancies.
The Louisiana Senate on Thursday passed a bill that would make it the first state in the nation to reclassify the abortion medications misoprostol and mifepristone as "controlled dangerous substances," making it illegal to possess them without a prescription. Republican Gov. Jeff Landry is expected to sign the bill into law. Caitlin Huey-Burns has more.
The Louisiana House of Representatives passed a bill Tuesday that would add two commonly used abortion pills to the state's list of controlled dangerous substances. CBS News campaign reporter Shawna Mizelle explains how the legislation would impact reproductive rights in the state.
When asked by TIME Magazine if states should monitor women's pregnancies to track abortions, former President Donald Trump said: "I think they might do that. Again, you'll have to speak to the individual states. Look, Roe v. Wade was all about bringing it back to the states." Molly Ball and Brakkton Booker join with analysis.
A study published in the Harvard Law Review found there was a spike in nationwide orders blocking federal policies during the Trump administration.
In the first major challenge to abortion rights since overturning Roe v. Wade, the Supreme Court on Tuesday heard oral arguments in a case that could determine nationwide access to mifepristone. The so-called abortion pill was used in nearly two-thirds of all abortions last year.
As the Supreme Court weighs access to the abortion pill, some doctors are sounding the alarm about a troubling trend of online misinformation involving birth control. Lauren Weber, health and science accountability reporter for The Washington Post, joins CBS News to explain.
The Supreme Court appeared skeptical Tuesday that a group of doctors demonstrated they had the proper basis to sue in federal court over the Food and Drug Administration's move to expand access to mifepristone, a pill used to terminate early pregnancies. Elizabeth Sepper, a law professor at the University of Texas, and Usham Upadhyay an associate professor at the University of California San Francisco, join CBS News with more.
Almost two years after overturning Roe v. Wade, Supreme Court justices heard arguments on access to the widely-used abortion pill mifepristone. CBS News chief legal correspondent Jan Crawford reports. Then, legal contributor Jessica Levinson joins with analysis.
The Supreme Court on Tuesday heard arguments on access to mifepristone, a pill that's taken with another drug to terminate an early pregnancy. The high court will weigh if the Food and Drug Administration adequately considered safety when it expanded access to the medication in 2016 and 2021. Robin Nunn, a federal trial attorney, joins CBS News with more.
The Supreme Court heard arguments Tuesday to restrict access to the widely used abortion pill mifepristone. Some justices who voted to overturn Roe v. Wade challenged those opposing the FDA's actions to broaden access to the pill. CBS News campaign reporters Shawna Mizelle and Aaron Navarro have more.
The Supreme Court heard arguments Tuesday on the move by the FDA to expand access to mifepristone, the drug used to terminate early pregnancies. CBS News' Shawna Mizelle breaks down the hearing's arguments.
The Supreme Court is hearing arguments Tuesday in a case about access to the widely used abortion pill mifepristone. CBS News correspondent Natalie Brand has more on the case and the demonstrators who have come to the court to make their voices heard.
The Supreme Court is set to hear oral arguments Tuesday on access to the abortion pill mifepristone. CBS News' Major Garrett and Shawna Mizelle, and Politico legal editor James Romoser, join to discuss the legal ramifications and how the case may affect the 2024 election.
Karen Lynch, CEO of CVS Health, discussed her company's decision to carry the abortion pill mifepristone, and cybersecurity threats in the wake of the UnitedHealth hack.